{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:49:26Z","timestamp":1782773366009,"version":"3.54.5"},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.kint.2019.12.020","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T05:01:26Z","timestamp":1584594086000},"page":"655-656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Improving human kidney function in renovascular disease with mesenchymal stem cell therapy"],"prefix":"10.1016","volume":"97","author":[{"given":"Kisha N.","family":"Sivanathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Toby","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2019.12.020_bib1","first-page":"393","article-title":"The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells","volume":"3","author":"Friedenstein","year":"1970","journal-title":"Cell Tissue Kinet"},{"key":"10.1016\/j.kint.2019.12.020_bib2","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal stromal cells: clinical challenges and therapeutic opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.kint.2019.12.020_bib3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12015-014-9495-2","article-title":"Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation","volume":"10","author":"Sivanathan","year":"2014","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.kint.2019.12.020_bib4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","article-title":"Mesenchymal stromal cells: sensors and switchers of inflammation","volume":"13","author":"Bernardo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.kint.2019.12.020_bib5","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/stem.1449","article-title":"Concise review: mesenchymal stem cell treatment for ischemic kidney disease","volume":"31","author":"Zhu","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.kint.2019.12.020_bib6","article-title":"Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial","volume":"21","author":"Tan","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2019.12.020_bib7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.kint.2019.11.022","article-title":"In a Phase 1a escalating clinical trial, autologous mesenchymal stem cell infusion for renovascular disease increases blood flow and the glomerular filtration rate while reducing inflammatory biomarkers and blood pressure","volume":"97","author":"Abumoawad","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.12.020_bib8","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1002\/stem.2075","article-title":"Interleukin-17A-induced human mesenchymal stem cells are superior modulators of immunological function","volume":"33","author":"Sivanathan","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.kint.2019.12.020_bib9","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.kint.2017.08.030","article-title":"IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2\/PGE2 pathway","volume":"93","author":"Bai","year":"2018","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253820300958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253820300958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:54:50Z","timestamp":1758761690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253820300958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0085253820300958"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2019.12.020","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving human kidney function in renovascular disease with mesenchymal stem cell therapy","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2019.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2019.11.022","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier, Inc., on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}